Health Catalyst, Inc. logo HCAT - Health Catalyst, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 12
HOLD 10
SELL 0
STRONG
SELL
0
| PRICE TARGET: $2.25 DETAILS
HIGH: $3.00
LOW: $1.75
MEDIAN: $2.00
CONSENSUS: $2.25
UPSIDE: 74.42%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Revenue
Revenue 311.1 306.6 295.9 276.2 241.9 188.8 154.9 112.6 73.1
Cost of Revenue 207.0 165.8 164.1 143.0 124.4 98.1 75.3 59.9 43.6
Gross Profit 104.1 140.8 131.8 133.2 117.6 90.8 79.6 52.7 29.4
Operating Expenses
R&D Expenses 49.8 58.0 72.6 75.7 62.7 53.5 46.3 38.6 28.5
SG&A Expenses 102.0 111.2 143.9 149.2 161.0 114.7 79.0 66.8 40.6
Other Expenses (11.6) 41.4 42.2 48.3 37.5 18.7 9.2 (0.0) (0.0)
Operating Expenses 140.2 210.6 258.7 273.2 261.2 186.9 134.5 112.8 75.0
Operating Income
Operating Income (36.1) (69.8) (126.9) (140.0) (143.7) (96.1) (54.9) (60.1) (45.5)
Interest Expense 16.4 17.1 7.3 7.2 17.3 13.7 6.3 2.6 2.0
Interest Income 7.5 18.0 16.4 5.7 0.8 2.1 2.8 0.6 0.5
Profitability
EBITDA 14.4 (10.7) (68.3) (82.9) (101.7) (85.9) (47.3) (52.1) (39.7)
EBIT (36.1) (52.1) (110.5) (134.4) (142.8) (104.6) (56.5) (60.1) (45.5)
Income Before Tax (177.3) (69.2) (117.8) (141.7) (160.1) (116.2) (60.0) (62.1) (47.0)
Income Tax Expense 0.7 0.3 0.4 (4.3) (6.9) (1.2) 0.1 (0.1) 0.0
Net Income (178.0) (69.5) (118.1) (137.4) (153.2) (115.0) (60.1) (62.0) (47.0)
Per Share Data
EPS (Basic) -2.55 -1.15 -2.09 -2.56 -3.23 -2.91 -3.21 -2.23 -1.69
EPS (Diluted) -2.55 -1.15 -2.09 -2.54 -3.23 -2.91 -3.21 -2.23 -1.69
Shares Outstanding 69.9 60.2 56.4 53.7 47.5 39.5 18.7 27.8 27.8
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Current Assets
Cash & Cash Equivalents 50.8 249.6 106.3 116.3 193.2 92.0 18.0 28.4 23.0
Short-Term Investments 44.9 142.4 211.5 247.2 251.8 178.9 210.2 4.8 28.5
Net Receivables 59.1 57.2 60.3 48.0 48.8 48.3 27.6 27.7 17.1
Inventory 0 0 0 0 0 0 0 0 0
Other Current Assets 14.4 16.5 15.4 16.3 14.6 0 0 0.6 0.8
Total Current Assets 169.3 465.6 393.4 427.8 508.4 329.8 264.2 66.9 71.4
Non-Current Assets
Property, Plant & Equipment 40.5 41.5 39.6 42.6 44.4 37.6 8.1 11.0 5.4
Goodwill 209.1 259.8 190.7 186.0 170.0 107.8 3.7 3.7 3.7
Intangible Assets 77.7 86.1 73.4 92.2 104.8 98.9 25.5 28.3 29.6
Long-Term Investments 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 6.1 6.0 4.7 3.7 4.5 3.6 0.8 1.1 0.2
Total Non-Current Assets 333.3 393.3 308.4 324.5 323.7 247.9 38.1 44.1 38.9
Total Assets 502.6 858.9 701.8 752.3 832.1 577.7 302.4 111.0 110.3
Current Liabilities
Account Payables 9.4 11.4 6.6 4.4 4.7 5.3 3.6 1.8 0.8
Short-Term Debt 5.4 231.2 0 0 0 0 2.8 1.3 0
Deferred Revenue 56.1 53.3 55.8 55.0 56.6 47.1 30.7 24.8 10.7
Other Current Liabilities 18.7 11.7 11.7 7.5 10.9 24.3 4.1 5.5 16.3
Total Current Liabilities 89.6 325.9 89.0 82.5 93.1 88.0 48.2 41.8 30.8
Non-Current Liabilities
Long-Term Debt 151.6 151.2 228.0 226.5 180.9 169.0 48.2 18.8 9.6
Deferred Tax Liabilities 0 0 0 0 0 0 0 (4.2) 0
Other Non-Current Liabilities 0.8 0.2 0.1 0.1 14.8 19.1 2.2 413.6 328.5
Total Non-Current Liabilities 167.3 167.9 245.9 244.8 216.9 213.6 53.5 443.9 339.0
Total Liabilities 256.9 493.7 334.9 327.3 310.0 301.6 101.7 485.7 369.7
Stockholders' Equity
Common Stock 1,608.8 1,552.7 1,484.1 1,424.7 0.1 0.0 0.0 0.0 0.0
Retained Earnings (1,364.6) (1,186.7) (1,117.2) (999.0) (878.9) (725.6) (610.5) (374.8) (259.5)
Accumulated Other Comprehensive Income 1.6 (0.8) 0.0 (0.6) (0.1) 0.1 0.1 (0.0) (0.0)
Total Stockholders' Equity 245.8 365.2 366.9 425.0 522.1 276.1 200.6 (374.8) (259.5)
Total Liabilities & Equity 502.6 858.9 701.8 752.3 832.1 577.7 302.4 111.0 110.3
Debt Metrics
Total Debt 171.2 402.3 249.1 248.0 204.6 195.3 52.7 26.9 12.6
Net Debt 120.4 152.6 142.8 131.7 11.4 103.3 34.6 (1.5) (10.4)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017
Operating Activities
Net Income (178.0) (69.5) (118.1) (137.4) (153.2) (115.0) (60.1) (62.0) (47.0)
Depreciation & Amortization 50.5 41.4 42.2 48.3 37.5 18.7 9.2 7.4 5.9
Stock-Based Compensation 27.0 40.1 55.8 72.1 65.1 38.0 17.8 4.2 4.2
Change in Working Capital (15.1) (0.7) (13.7) (13.9) 4.6 (3.8) (1.3) 9.8 (0.2)
Other Non-Cash Items 116.2 3.1 0.8 0.2 29.9 37.3 2.1 0.5 0.2
Operating Cash Flow 0.7 14.6 (33.1) (35.3) (23.1) (26.1) (32.2) (40.3) (36.8)
Investing Activities
Capital Expenditure (1.0) (16.4) (14.3) (17.4) (18.5) (10.5) (4.3) (2.5) (3.3)
Acquisitions (41.1) (80.3) (11.4) (27.8) (46.8) (101.7) 1.9 0.2 0.9
Purchases of Investments (65.1) (168.3) (290.8) (309.0) (261.4) (189.5) (256.0) (14.0) (46.4)
Sales/Maturities of Investments 163.9 242.1 336.8 315.2 186.9 219.1 50.7 37.9 72.1
Other Investing Activities (20.5) (14.8) (13.0) (15.2) 0.0 0.0 (1.9) (0.2) (0.8)
Investing Cash Flow 36.2 (22.9) 20.3 (39.0) (139.7) (82.6) (209.6) 21.4 22.4
Financing Activities
Net Debt Issuance (232.3) 151.3 0 0 0 165.4 25.3 9.9 9.8
Stock Repurchased (5) 0 (1.8) (8.4) 0 0 0 (8.7) 0
Dividends Paid 0 0 0 0 0 0 0 0 0
Other Financing Activities 0 (2.2) 4.5 5.8 18.9 (23.4) (0.7) 23.1 15.1
Financing Cash Flow (235.8) 151.7 2.7 (2.6) 264.1 182.6 231.4 24.3 24.9
Cash Position
Net Change in Cash (198.8) 143.4 (10.0) (76.9) 101.3 73.9 (10.4) 5.5 10.4
Cash at Beginning 249.6 106.3 116.3 193.2 92.0 18.0 28.4 23.0 12.5
Cash at End 50.8 249.6 106.3 116.3 193.2 92.0 18.0 28.4 23.0
Free Cash Flow (0.2) (1.8) (47.4) (52.7) (41.6) (36.6) (36.5) (42.8) (40.2)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017
Income Statement
Revenue 311.1 306.6 295.9 276.2 241.9 188.8 154.9 112.6 73.1
Gross Profit 104.1 140.8 131.8 133.2 117.6 90.8 79.6 52.7 29.4
Operating Income (36.1) (69.8) (126.9) (140.0) (143.7) (96.1) (54.9) (60.1) (45.5)
Net Income (178.0) (69.5) (118.1) (137.4) (153.2) (115.0) (60.1) (62.0) (47.0)
EPS (Diluted) -2.55 -1.15 -2.09 -2.54 -3.23 -2.91 -3.21 -2.23 -1.69
Balance Sheet
Cash & Equivalents 50.8 249.6 106.3 116.3 193.2 92.0 18.0 28.4 23.0
Total Assets 502.6 858.9 701.8 752.3 832.1 577.7 302.4 111.0 110.3
Total Debt 171.2 402.3 249.1 248.0 204.6 195.3 52.7 26.9 12.6
Stockholders' Equity 245.8 365.2 366.9 425.0 522.1 276.1 200.6 (374.8) (259.5)
Cash Flow
Operating Cash Flow 0.7 14.6 (33.1) (35.3) (23.1) (26.1) (32.2) (40.3) (36.8)
Capital Expenditure (1.0) (16.4) (14.3) (17.4) (18.5) (10.5) (4.3) (2.5) (3.3)
Free Cash Flow (0.2) (1.8) (47.4) (52.7) (41.6) (36.6) (36.5) (42.8) (40.2)